Login

Healthcare

00:10:00
Beleave Inc. CEO Andrew Wnek on Expanding Operations and Strategic Research Partnerships | Andrew Wnek, CEO, Beleave Inc.
00:10:00
Abingdon Health CEO Chris Yates Discusses London Listing and Growth Strategy | Chris Yates, CEO, Abingdon Health PLC.
00:10:00
Beleave Inc. CFO Bojan Krasic Discusses Recent Developments and Expansion Plans | Bojan Krasic, CFO, Beleave Inc.
00:10:00
From Cultivation to Market: Beleave Inc.'s Vision for Cannabis and Future Innovations | Bojan Krasic, CEO, Beleave Inc.
00:10:00
Beleave Inc. CEO Roger Ferreira Presents at CSE Day Spring 2016 in Toronto | Roger Ferreira, CEO, Beleave Inc.
00:10:00
Beleave Inc. CEO Bill Panagiotakopoulos on Expanding Cannabis Footprint and New Product Launches | Bill Panagiotakopoulos, CEO, Beleave Inc.
00:10:00
Abingdon Health CEO Chris Yates Discusses Interim Results & Growth Outlook | Chris Yates, CEO, Abingdon Health PLC.
00:10:00
In-Depth Conversation with Supriya Lifescience MD Satish Wagh and Director Saloni Wagh: The Journey, Legacy, and Future Vision | Saloni Wagh, Director, Supriya Lifescience Limited.
00:10:00
Dr. Saloni Wagh Discusses Supriya Lifescience's Growth Strategy and Market Leadership | Saloni Wagh, Director, Supriya Lifescience Limited.
00:10:00
Christopher Gallen on Building a Biotech Business in Asia | Christopher Gallen, President, SK Biopharmaceuticals, Korea.
00:10:00
Supriya Lifescience IPO Opens on December 16; Aiming to Raise ₹500 Crore at ₹265-274 Price Band | Satish Wagh, Chairman, Supriya Lifescience Limited.
00:10:00
Supriya Lifescience MD Satish Wagh and Director Saloni Wagh on Q1 Results, Profits, and Future Expansion | Satish Wagh, Chairman, Supriya Lifescience Limited.
00:10:00
IPO Review of Supriya Lifescience Ltd: Insights from Saloni Wagh and Satish Wagh | Satish Wagh, Chairman, Supriya Lifescience Limited.
00:10:00
Supriya Lifescience Limited Earnings Review & Business Outlook by Director Saloni Wagh | Saloni Wagh, Director, Supriya Lifescience Limited.
00:10:00
Michelle Xia on Akeso's Groundbreaking Progress with Cadonilimab | Michelle Xia, CEO, Akeso Inc.
00:10:00
Michelle Xia on Akeso's Rapid Expansion and Groundbreaking Drug Development | Michelle Xia, CEO, Akeso Inc.

© 2026 Nehu